TERN (TERN)
Biotechnology
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Live quote temporarily unavailable — press releases and news are still shown below.
No company overview is available for TERN yet.
Peers in Biotechnology
All in industry →Vertex Pharmaceuticals Incorporated
Regeneron Pharmaceuticals, Inc.
argenx SE
Alnylam Pharmaceuticals, Inc.
BeOne Medicines AG
Insmed Incorporated
Royalty Pharma plc
BioNTech SE
Roivant Sciences Ltd.
Moderna, Inc.
Recent press releases
April 2026
Terns Pharmaceuticals, Inc. — SC 14D9 Filing
# 🧾 What This Document Is This is a **Schedule 14D-9**, a formal "solicitation/recommendation statement." Think of it as Terns' official letter to its shareholders. Its job? To explain the company's board of directors' recommendation on a **major event**—in this case, an acquisition offer from ph
SEC filings
All filings →Insider trades
All insider trades →TERN has no reported insider trades in the last 90 days.